Comments
Loading...

Aerovate Therapeutics

AVTENASDAQ
Logo brought to you by Benzinga Data
$2.45
0.2611.87%
At close: -
$2.49
0.041.63%
After Hours: 6:27 PM EDT
15 minutes delayed
Jade Biosciences announced today it will be merged with Aerovate Therapeutics (AVTE)

Aerovate Therapeutics (NASDAQ:AVTE) Stock Quotes, Forecast and News Summary

Aerovate Therapeutics Stock (NASDAQ: AVTE) stock price, news, charts, stock research, profile.

Open$2.78
Close$2.45
Volume / Avg.32.99M / 216.00K
Day Range$2.45 - $3.00
52 Wk Range1.25 - 32.42
Market Cap$71.88M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
67
Short Interest
5.87%
Days to Cover3.22

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
May
1
3
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
1.9
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$2.78
Close$2.45
Volume / Avg.32.99M / 216.00K
Day Range$2.45 - $3.00
52 Wk Range1.25 - 32.42
Market Cap$71.88M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
67
Short Interest
5.87%
Days to Cover3.22

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
AVTE
SYRS

FAQ

Q

How do I buy Aerovate Therapeutics (AVTE) stock?

A

You can purchase shares of Aerovate Therapeutics (NASDAQ:AVTE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aerovate Therapeutics (AVTE) competitors?

Q

What is the forecast, or price target, for Aerovate Therapeutics (AVTE) stock?

A

Aerovate Therapeutics has a consensus price target of $11.75.

Q

What is the current price for Aerovate Therapeutics (AVTE)?

A

The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $2.49 last updated October 31, 2024 at 5:46 PM EDT.

Q

Does Aerovate Therapeutics (AVTE) pay a dividend?

A

There are no upcoming dividends for Aerovate Therapeutics.

Q

When is Aerovate Therapeutics (NASDAQ:AVTE) reporting earnings?

A

Aerovate Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.

Q

Is Aerovate Therapeutics (AVTE) going to split?

A

There is no upcoming split for Aerovate Therapeutics.

Q

What sector and industry does Aerovate Therapeutics (AVTE) operate in?

A

Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch